Glucose Metabolism and Glucose Transporters in Head and Neck Squamous Cell Carcinoma
- PMID: 39324504
- DOI: 10.1080/07357907.2024.2407424
Glucose Metabolism and Glucose Transporters in Head and Neck Squamous Cell Carcinoma
Abstract
Head and neck squamous cell carcinoma ranks seventh globally in malignancy prevalence, with persistent high mortality rates despite treatment advancements. Glucose, pivotal in cancer metabolism via the Warburg effect, enters cells via glucose transporters, notably GLUT proteins. Glycolysis, aerobic oxidation, and the pentose phosphate pathway in glucose metabolism significantly impact HNSCC progression. HNSCC exhibits elevated expression of glucose metabolism enzymes and GLUT proteins, correlating with prognosis. Heterogeneity in HNSCC yields varied metabolic profiles, influenced by factors like HPV status and disease stage. This review highlights glucose metabolism's role and potential as therapeutic targets and cancer imaging tracers in HNSCC.
Keywords: Head and neck squamous cell carcinoma; glucose metabolism; glucose transporter; glycolysis; oxidative phosphorylation.
Similar articles
-
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.J Hematol Oncol. 2017 Jan 7;10(1):11. doi: 10.1186/s13045-016-0372-0. J Hematol Oncol. 2017. PMID: 28061796 Free PMC article.
-
Comparative metabolic analysis in head and neck cancer and the normal gingiva.Clin Oral Investig. 2018 Mar;22(2):1033-1043. doi: 10.1007/s00784-017-2185-0. Epub 2017 Jul 22. Clin Oral Investig. 2018. PMID: 28735466
-
TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.Clin Cancer Res. 2010 Feb 1;16(3):857-66. doi: 10.1158/1078-0432.CCR-09-2604. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103683 Free PMC article.
-
Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets.Head Neck. 2012 Feb;34(2):282-90. doi: 10.1002/hed.21664. Epub 2011 Feb 14. Head Neck. 2012. PMID: 21322078 Free PMC article. Review.
-
Targeting Signalling Cross-Talk between Cancer Cells and Cancer-Associated Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer.Anticancer Agents Med Chem. 2021;21(11):1369-1378. doi: 10.2174/1871520620666200721135230. Anticancer Agents Med Chem. 2021. PMID: 32698754 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical